TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea flag South Korea · Delayed Price · Currency is KRW
451.00
-31.00 (-6.43%)
May 21, 2026, 1:20 PM KST
Market Cap17.37B -61.5%
Revenue (ttm)43.16B +14.0%
Net Income-11.46B
EPS-238.83
Shares Out36.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume642,844
Average Volume625,074
Open493.00
Previous Close482.00
Day's Range450.00 - 494.00
52-Week Range451.00 - 4,433.33
Betan/a
RSI27.95
Earnings DateMay 22, 2026

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea. [Read more]

Sector Technology
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 200230
Full Company Profile

Financial Performance

In 2025, TELCON RF PHARMACEUTICAL.'s revenue was 43.16 billion, an increase of 13.99% compared to the previous year's 37.87 billion. Losses were -11.46 billion, -56.48% less than in 2024.

Financial Statements